Evolution of the Average Target: Docebo Inc.

Evolution of the Target Price: Docebo Inc.

Changes in Analyst Recommendations: Docebo Inc.

f22.wsNwjzo_fR2xTA4qeWcZCod5gbwxNvZG6CdAUi2LdJw.mPIJ7nh2GUzZf3RIIQQqY8At4slaD6dr0EQlH1_kRe-K-jjuDUgbcIMoVw~fe7dfc45b3945fd134ccd83c62a3040d
04-23 CIBC Confirms Outperformer Rating and Target of US$28 on Docebo After Inspire 2026 Conference MT
04-22 Stifel Canada Sees Potential Upside For Docebo MT
04-17 CIBC Lowers Price Target on Software and Services Stocks MT
01-30 CIBC Confirms Outperformer Rating on Docebo and Raises Target to US$34.00 MT
01-21 Stifel Canada on Docebo Acquiring 365Talents MT
01-21 CIBC Maintained Its Outperformer Rating on Docebo As It Acquires 365Talents MT
12-15 CIBC's Top Picks For 2026 Software Sector MT
12-15 CIBC's Top Picks For 2026 Software Sector MT
11-07 Docebo Brief: Revising Financial Guidance for Fiscal Year ended December 31, 2025 MT
11-05 Oppenheimer Initiates Coverage on Docebo With Outperform Rating, CA$49.38 Price Target MT
09/06/25 Cantor Fitzgerald Initiates Docebo at Overweight With CA$47.85 Price Target MT
12/05/25 Docebo Shares Lower After Morgan Stanley Downgrade MT
12/05/25 Morgan Stanley Downgrades Docebo to Equalweight From Overweight After 'Disappointing' Q1 Update, Cuts Price Target to $32 From $41 MT
12/05/25 National Bank Downgrades Docebo to Sector Perform From Outperform, Adjusts Price Target to $35 From $45 MT
08/04/25 National Bank Says Docebo Promoting Farber to CFO is "Not Surprising" MT
03/03/25 Docebo Upgraded to Outperform at ATB MT
21/10/24 CIBC Raises Price Target on Six Software and Services Companies MT
13/05/24 Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating MT
19/04/24 Morgan Stanley Trims Price Target on Docebo to $65 From $67, Keeps Overweight Rating MT
26/02/24 Scotiabank Raises Docebo's Price Target to $65 From $60, Keeps Sector Outperform Rating MT
26/02/24 Morgan Stanley Adjusts Price Target on Docebo to $67 From $63, Keeps Overweight Rating MT
22/12/23 Morgan Stanley Boosts Price Target on Docebo to $63 From $53, Keeps Overweight Rating MT
23/11/23 Docebo Maintained at Buy at Stifel GMP Following C-Suite Changes; Price Target Raised to US$60.00 MT
14/11/23 Needham Starts Docebo With Buy Rating, Price Target is $56 MT
10/11/23 Goldman Sachs Raises Price Target on Docebo to $44 From $39, Maintains Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - -
+17.84%
+6.52%
+26.62%
+21.03%
+40.79%
+32.13%
+19.73%
+9.87%
+4.84%
Average +19.93%
Weighted average by Cap. +17.44%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.79USD
Average target price
31.57USD
Spread / Average Target
+27.36%
High Price Target
31.57USD
Spread / Highest target
+27.36%
Low Price Target
31.57USD
Spread / Lowest Target
+27.36%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Oppenheimer
Cantor Fitzgerald
Morgan Stanley
National Bank
ATB Capital
Needham & Co.
Scotiabank
Stifel GMP
Goldman Sachs
National Bank Financial
Canaccord Genuity
Stifel Nicolaus
Berenberg Bank
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.79USD
Average target price
31.57USD
Spread / Average Target
+27.36%

Quarterly revenue - Rate of surprise